Tyna Dao, Nakissa Sadrieh. A CDER perspective: Landscape of New Approach Methodologies (NAMs) submitted in drug development programs. Regulatory toxicology and pharmacology: RTP. 2026;165:106007. doi:10.1016/j.yrtph.2025.106007
Min Liu, Jonathan G. Faris, Amanda R. Panfil, Cody J. Warren. How new approach methods are reshaping virology research. Journal of Virology. 2026;100(4):e0132625. doi:10.1128/jvi.01326-25
Kang Zhang, Xin Yang, Yifei Wang, et al. Artificial intelligence in drug development. Nature Medicine. 2025;31(1):45-59. doi:10.1038/s41591-024-03434-4
Daniel J. Shiwarski, Andrew R. Hudson, Joshua W. Tashman, et al. 3D bioprinting of collagen-based high-resolution internally perfusable scaffolds for engineering fully biologic tissue systems. Science Advances. 2025;11(17):eadu5905. doi:10.1126/sciadv.adu5905
Maria T. Baltazar, Sophie Cable, Richard Cubberley, et al. Making safety decisions for a sunscreen active ingredient using next-generation risk assessment: Benzophenone-4 case study. ALTEX. 2025;42(3):511-530. doi:10.14573/altex.2501201
David Moher, Anna Catharina Vieira Armond. Publisher and journal reciprocity for peer review: Not so much. Accountability in Research. 2025;32(5):832-837. doi:10.1080/08989621.2025.2450451
Decio L. Eizirik, Priscila L. Zimath. Diabetes research enters the biobank era: searching for the truth in a deep well. The Journal of Clinical Investigation. 2025;135(23):e199728. doi:10.1172/JCI199728
Mathieu Vinken, Daniela Grimm, Sarah Baatout, et al. Taking the 3Rs to a higher level: replacement and reduction of animal testing in life sciences in space research. Biotechnology Advances. 2025;81:108574. doi:10.1016/j.biotechadv.2025.108574
Eryn Slankster-Schmierer. Modernizing toxicology: The importance of accessible NAM training. Toxicology Letters. 2025;406:38-39. doi:10.1016/j.toxlet.2025.02.011
Melpomeni Platani, Hao Jiang, Lindsay Davidson, et al. Screening for variable drug responses using human iPSC cohorts. PloS One. 2025;20(5):e0323953. doi:10.1371/journal.pone.0323953